Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Planned dose in targets

From: Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer

   PSV-PCTV PCTV-PGTVs   PGTVs
Patient Plan Prescription Inhomogeneity Conformity Prescription Inhomogeneity Conformity Prescription Inhomogeneity Conformity
Volumea D min b D max b D mean c IC CN Volume D min b D max b D mean c IC CN Volumea D min b D max b D mean c IC CN
1 Proton 99.1 % 97.2 % 180.2 % 68.1 0.614 0.043 99.3 % 97.7 % 132.9 % 83.5 0.296 0.342 98.9 % 99.2 % 103.8 % 91.9 0.045 0.189
IMRT 99.1 % 95.6 % 152.2 % 63.6 0.448 0.048 99.3 % 96.2 % 133.0 % 82.1 0.316 0.404 98.9 % 98.8 % 107.0 % 93.3 0.079 0.319
2 Proton 99.3 % 99.0 % 180.0 % 70.1 0.582 0.039 98.8 % 98.3 % 132.9 % 85.1 0.285 0.328 98.4 % 99.7 % 103.8 % 91.2 0.041 0.197
IMRT 99.3 % 96.6 % 158.1 % 64.1 0.484 0.043 98.8 % 96.2 % 134.0 % 82.7 0.322 0.422 98.4 % 96.3 % 108.2 % 93.5 0.114 0.336
3 Proton 98.5 % 95.0 % 165.7 % 66.8 0.533 0.049 98.5 % 99.3 % 131.1 % 80.7 0.276 0.431 98.2 % 99.4 % 102.2 % 91.1 0.027 0.189
IMRT 98.5 % 95.6 % 148.4 % 62.2 0.428 0.052 98.5 % 95.3 % 133.9 % 81.0 0.334 0.542 98.2 % 96.8 % 106.2 % 93.3 0.091 0.286
4 Proton 99.4 % 97.8 % 178.2 % 67.0 0.604 0.076 99.3 % 97.2 % 132.3 % 84.1 0.294 0.397 98.8 % 99.2 % 103.3 % 91.2 0.041 0.215
IMRT 99.4 % 98.0 % 155.6 % 62.4 0.465 0.076 99.3 % 95.7 % 133.6 % 82.9 0.321 0.443 98.8 % 97.3 % 108.4 % 93.9 0.106 0.346
5 Proton 99.4 % 95.4 % 181.7 % 72.9 0.597 0.054 99.1 % 98.6 % 132.3 % 84.5 0.281 0.323 98.7 % 98.9 % 103.9 % 91.4 0.049 0.221
IMRT 99.4 % 96.8 % 152.6 % 64.9 0.433 0.069 99.1 % 95.0 % 135.5 % 81.0 0.350 0.491 98.7 % 97.3 % 108.8 % 94.5 0.109 0.459
6 Proton 98.6 % 96.0 % 183.5 % 71.3 0.619 0.054 99.2 % 98.3 % 134.2 % 83.5 0.302 0.193 99.3 % 99.7 % 104.8 % 92.2 0.050 0.219
IMRT 98.6 % 95.2 % 166.9 % 65.1 0.554 0.055 99.2 % 96.3 % 134.9 % 80.4 0.337 0.220 99.3 % 98.9 % 106.6 % 93.1 0.074 0.386
7 Proton 98.9 % 98.2 % 181.9 % 72.7 0.581 0.056 99.6 % 99.3 % 134.2 % 85.7 0.286 0.281 98.5 % 98.4 % 103.9 % 92.0 0.053 0.237
IMRT 98.9 % 95.2 % 177.2 % 63.4 0.652 0.051 99.6 % 96.9 % 137.0 % 81.4 0.347 0.313 98.5 % 97.9 % 110.0 % 95.3 0.114 0.415
8 Proton 98.8 % 95.4 % 172.0 % 65.6 0.589 0.069 99.3 % 98.1 % 135.9 % 84.8 0.313 0.313 99.0 % 99.4 % 107.3 % 92.0 0.077 0.218
IMRT 98.8 % 96.4 % 158.5 % 63.1 0.496 0.074 99.3 % 96.6 % 134.5 % 81.0 0.328 0.346 99.0 % 99.1 % 108.2 % 94.0 0.087 0.341
9 Proton 98.2 % 92.5 % 183.7 % 72.8 0.632 0.063 99.5 % 97.9 % 132.6 % 86.6 0.282 0.259 99.3 % 99.4 % 103.3 % 91.9 0.038 0.255
IMRT 98.2 % 97.2 % 168.8 % 64.2 0.562 0.060 99.5 % 98.0 % 136.8 % 83.5 0.326 0.268 99.3 % 99.0 % 106.8 % 93.7 0.075 0.349
10 Proton 99.3 % 96.4 % 143.7 % 65.5 0.363 0.012 99.6 % 99.0 % 132.2 % 80.4 0.290 0.414 98.0 % 99.6 % 103.3 % 91.3 0.037 0.221
IMRT 99.3 % 99.2 % 148.8 % 64.9 0.385 0.012 99.6 % 95.9 % 136.5 % 80.6 0.354 0.477 98.0 % 96.6 % 108.7 % 94.2 0.116 0.341
  1. aMinimum volume to which prescribed dose is planned
  2. bRelative to the prescribed dose in percent
  3. cIn Gy